News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
284,315 Results
Type
Article (14980)
Company Profile (300)
Press Release (269029)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (80721)
Career Advice (163)
Deals (13459)
Drug Delivery (39)
Drug Development (50958)
Employer Resources (31)
FDA (5908)
Job Trends (5208)
News (146436)
Policy (10172)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (926)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21932)
ALS (125)
Alzheimer's disease (1032)
Antibody-drug conjugate (ADC) (241)
Approvals (6105)
Artificial intelligence (259)
Autoimmune disease (114)
Automation (9)
Bankruptcy (108)
Best Places to Work (4594)
BIOSECURE Act (6)
Biosimilars (101)
Biotechnology (230)
Bladder cancer (103)
Brain cancer (46)
Breast cancer (352)
Cancer (3158)
Cardiovascular disease (237)
Career advice (148)
Career pathing (7)
CAR-T (221)
CDC (5)
Cell therapy (567)
Cervical cancer (14)
Clinical research (43897)
Collaboration (1154)
Company closure (2)
Compensation (596)
Complete response letters (39)
COVID-19 (1101)
CRISPR (86)
C-suite (556)
Cystic fibrosis (112)
Data (4350)
Denatured (15)
Depression (92)
Diabetes (255)
Diagnostics (1431)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (188)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (216)
Earnings (32087)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (52075)
Executive appointments (627)
FDA (7666)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (984)
Gene editing (182)
Generative AI (21)
Gene therapy (490)
GLP-1 (504)
Government (1158)
Grass and pollen (3)
Guidances (168)
Healthcare (6648)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (40)
Indications (66)
Infectious disease (1206)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (166)
Interviews (18)
IPO (7405)
IRA (12)
Job creations (874)
Job search strategy (130)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (243)
Leadership (9)
Legal (1411)
Liver cancer (41)
Longevity (11)
Lung cancer (425)
Lymphoma (249)
Machine learning (24)
Management (7)
Manufacturing (379)
MASH (130)
Medical device (2774)
Medtech (2783)
Mergers & acquisitions (6680)
Metabolic disorders (725)
Multiple sclerosis (104)
NASH (13)
Neurodegenerative disease (231)
Neuropsychiatric disorders (70)
Neuroscience (1954)
Neurotech (1)
NextGen: Class of 2026 (2058)
Non-profit (868)
Now hiring (30)
Obesity (329)
Opinion (125)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (232)
Partnered (12)
Patents (302)
Patient recruitment (331)
Peanut (43)
People (26920)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15545)
Phase 2 (20377)
Phase 3 (12897)
Pipeline (3277)
Policy (90)
Postmarket research (861)
Preclinical (6566)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (239)
Rare diseases (652)
Real estate (1464)
Recruiting (12)
Regulatory (9984)
Reports (19)
Research institute (975)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (183)
Series B (137)
Service/supplier (2)
Sickle cell disease (78)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2024)
State (1)
Stomach cancer (5)
Supply chain (33)
Tariffs (18)
The Weekly (62)
Vaccines (336)
Venture capital (69)
Weight loss (173)
Women's health (25)
Worklife (2)
Date
Today (55)
Last 7 days (324)
Last 30 days (1173)
Last 365 days (17943)
2026 (1713)
2025 (18193)
2024 (20650)
2023 (22542)
2022 (27003)
2021 (28039)
2020 (23546)
2019 (16377)
2018 (11856)
2017 (13870)
2016 (11966)
2015 (14486)
2014 (10488)
2013 (7635)
2012 (7683)
2011 (7711)
2010 (7528)
Location
Africa (158)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18338)
Australia (3126)
California (7113)
Canada (1874)
China (776)
Colorado (247)
Connecticut (253)
Delaware (237)
Europe (39500)
Florida (942)
Georgia (212)
Hawaii (2)
Idaho (17)
Illinois (396)
India (35)
Indiana (161)
Iowa (8)
Japan (225)
Kansas (82)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (742)
Massachusetts (5597)
Michigan (110)
Minnesota (247)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (33)
New Hampshire (21)
New Jersey (1654)
New Mexico (13)
New York (1763)
North Carolina (840)
North Dakota (6)
Northern California (3487)
Ohio (178)
Oklahoma (11)
Oregon (24)
Pennsylvania (1282)
Puerto Rico (9)
Rhode Island (25)
South America (220)
South Carolina (9)
Southern California (2823)
Tennessee (40)
Texas (907)
United States (23467)
Utah (96)
Virginia (137)
Washington D.C. (37)
Washington State (592)
West Virginia (1)
Wisconsin (47)
284,315 Results for "neos therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neomorph Announces First Patient Dosed in Phase 1/2 Trial Evaluating NEO-811 For the Treatment of Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
February 4, 2026
·
2 min read
Press Releases
Translational Data and Significant Pathologic Response Rates from EFTISARC-NEO Phase II Highlighted in Oral Presentation at CTOS 2025
November 14, 2025
·
7 min read
Press Releases
PlasCred Circular Innovations Inc. Engages Financial Advisor to Lead Neos Facility Capital Raise
October 7, 2025
·
6 min read
Press Releases
Primary Endpoint Met in EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma and Data Presented at ESMO Congress 2025
October 21, 2025
·
5 min read
Press Releases
Medicenna and Fondazione Melanoma Onlus Collaborate to Advance MDNA11 Before First-Line Therapy in a Randomized Neoadjuvant Combination Trial, “NEO-CYT”, in High-Risk, Surgically Resectable Stage III Melanoma
November 6, 2025
·
9 min read
Press Releases
PlasCred Awarded $5 Million Grant from Emissions Reduction Alberta to Advance Neos Facility
July 23, 2025
·
7 min read
Press Releases
Immutep Announces Data from EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma Accepted for Oral Presentation at CTOS 2025
September 9, 2025
·
2 min read
Press Releases
HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics
February 3, 2026
·
3 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Press Releases
Patient Enrolment Completed for EFTISARC-NEO Phase II Trial
January 22, 2025
·
2 min read
1 of 28,432
Next
